Please note, the law has been passed but it has not yet gone into effect. The Secretary of Health and Human Services and SAMHSA are working to develop regulations for implementation and we will pass that news along as it becomes available to us. Please do not attempt to prescribe buprenorphine until the regulations go into effect.
IntNSA applauds the momentous legislation, Comprehensive Addiction and Recovery Act of 2016 (CARA) passed by USA Congress yesterday
A giant step forward was made yesterday with the passing of CARA legislation towards the effort to reduce morbidities and mortalities associated with the opioid epidemic affecting so many Americans across our country. As the premiere organization for nurses working with those with substance use disorders, IntNSA has long advocated for advanced practice registered nurses (APRN) to be given the authority to prescribe buprenorphine, a medication for opioid use disorders. Inherent in this legislation, it is stated:
*Expansion of office-based treatment by allowing nurse practitioners and physician assistants to prescribe buprenorphine for opioid addiction*
This outstanding news is just one element of the CARA legislation that will address a full range of needed services, from primary prevention to recovery support, to expand access to treatment services for opioid use disorders.
IntNSA is working to develop strategies to address mandatory training requirements for APRNs to prescribe buprenorphine. We will put out updates as we obtain this information. A huge thank you to many of you who wrote letters of support to your representatives that helped to facilitate passage of this legislation!